Neuropathix

@Neuropathix subsidiary @Kannalife Awarded $2.97 Million Grant from National Institute of Neurological Disorders and Stroke (NINDS) $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #PainMonth2021 finance.yahoo.com/news/neuropath…

Exciting news! Join @Neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit in Boston, Nov 18-20! Don’t miss insights on #Cannabinoids #PeripheralNeuropathy #Neuroscience #MedicalResearch #Innovation #GPCR #GPR55 #CIPN …nabinoid-derived-drug-development.com/speaker/dean-p…

Join @neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit November 18-20, 2024 | Boston, MA hosted by @HansonWade #kannalife #gpcr #gpr55 #nlrp3 #ncx1 #kls13019 #neuro #inflammation #mitochondria …nabinoid-derived-drug-development.com/speaker/dean-p…

1,4 Mio € von @MichaelJFoxOrg für Chi Wang Ip @Uniklinikum_Wue & Partnern @Kannalife #Atuka. Sie untersuchen am spez. Mausmodell, ob KLS-13019, das strukturell mit Cannabinoiden verwandt ist, ein wirksames Medikament gegen #Parkinson sein könnte. nachrichten.idw-online.de/2024/07/09/14-…

@Kannalife featured in @parkinsonstory - @MichaelJFoxOrg $1.49M grant to advance preclinical research into #KLS13019 - #Parkinsons #ParkinsonsResearch #Neuroinflammation #MitochondrialDysfunction #CannabinoidTherapeutic #Kannalife #MJFF parkinsonsnewstoday.com/news/mjff-gran…

@Kannalife secures $1.49M from @MichaelJFoxOrg for #ParkinsonsResearch! This funding will boost the development of #KLS13019, addressing #neuroinflammation and #mitochondrialdysfunction. #Biotech #Innovation #CannabinoidTherapeutics #Kannalife #MJFF globenewswire.com/news-release/2…

@Kannlife CEO Dean Petkanas interview at @IAmBiotech #BIO2024 by Life Science Success Podcast #neuroprotection #cannabinoidtherapeutics #nlrp3 #gpcr #gpr55 #mitochondria #ncx1 #antiinflammatory youtube.com/watch?v=MB_YtM…

@Kannalife selected by @NIH as one of 30 Companies to present at @BIOConvention in San Diego. Presentation Tues June 4, 2024 @ 4:30 PM in Company Presentation Theater 3. Plus visit us NIH booth #825 on Tues June 4 @ 11:56 AM #BIO #NIH #Kannalife #Biotech convention.bio.org/speakers/dean-…

Exciting times @BioNJ_Org 🧬 Dean Petkanas of @Neuropathix @Kannalife sees New Jersey as the ultimate hub for life sciences. With 50% of attendees agreeing, NJ proves it's a leader in biotech! @ROINJNews #BioNJ #LifeSciences #Biotech #Pharma #Innovation roi-nj.com/2024/05/15/opi…

@Kannalife #Research Alert! Uncovering link between #KLS13019 & #GPR55 receptor - promising role in reducing #inflammation from chemotherapy-induced #peripheralneuropathy. #Cannabinoid #Innovation #GPCR #CIPN #NeuroPain #Mitochondria rdcu.be/dFqru

Dean Petkanas CEO of @Neuropathix @Kannalife presenting “#KLS13019 - A Remarkable #NonOpioid Drug Discovery for the #Treatment of #NeuroPain” - Tune in on April 2, 2024 @ 11:30am EST / 8:30am PST - us02web.zoom.us/j/88549236999

Join @Neuropathix at the 2023 @LifeSciSummit by @NIH on Oct 11, 2023 and see our subsidiary @Kannalife selected to take the stage at the Alexandria Center for Life Science in NYC Learn more: lifesciencessummit.org/presenters-23/ #Kannalife #Neuropathix #LifeSciSummit #Biotech #Innovation

Today is the 12 year anniversary of founding @Neuropathix subsidiary @kannalife. $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd youtube.com/watch?v=cTtD03…

@Neuropathix CEO Dean Petkanas Interview on #ConciergeforBetterLiving with @DocRob $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #cbd #cannabidiol #nonopioid #opioidcrisis #neuropathicpain #pain #painmanagement #NIH #HEALInitiative #opioidalternative cannabisradio.com/podcasts/conci…

@AAOA_tweets @ncl_tweets nasdaq.com/articles/why-o…

@nonopioidchoice nasdaq.com/articles/why-o…

In order to address the opioid crisis we need new and innovative solutions. In a recent op-ed written by our Executive Director, Chris Fox, he urges Congress to look beyond previously tried, yet unsuccessful methods. Read more here: bit.ly/3ypD1G1

Time to end this crisis now!

@Neuropathix CEO Dean Petkanas pens Op-Ed on Why Opioids controlled the Pain Management Market and What's Next. $NPTX #NPTX #Neuropathix #KLS13019 #Kannalife #opioids #opioidcrisis #pain #painmanagement #nonopioids #NIH #NINDS #HEALInitiative nasdaq.com/articles/why-o…

@FixOpioidCrisis nasdaq.com/articles/why-o…

@OpioidCrisis__ nasdaq.com/articles/why-o…

@OCRFund nasdaq.com/articles/why-o…